Trials / Completed
CompletedNCT02682199
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
Prospective Evaluation of Patient-Reported Xerostomia After Whole Brain Radiation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.
Detailed description
The parotids have not been traditionally considered an organ at risk / avoidance structure in whole brain radiation. However, patients receiving whole brain radiation sometimes complain of dry mouth. Investigators hypothesize that standard whole brain radiation fields cause an acute measurable increase in xerostomia at one month post-radiation, and that the severity of xerostomia is related to the dose received by the parotids. In this study, investigators will use the validated University of Michigan Xerostomia Questionnaire to prospectively collect baseline and post-radiation xerostomia scores up to 6 months after treatment. The radiation dose to the parotids will be evaluated to assess whether there is a dose-toxicity relationship. Investigators anticipate a total accrual of 60 patients with a goal of 48 evaluable patients.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-05-01
- Completion
- 2018-08-30
- First posted
- 2016-02-15
- Last updated
- 2019-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02682199. Inclusion in this directory is not an endorsement.